Human Metabolome Technologies, Inc. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Net Sales

466.84

192.38

188.63

581.89

410.31

274.17

230.12

Other Operating Income

0.00

Total Operating income

466.84

192.38

188.63

581.89

410.31

274.17

230.12

Raw Material Cost

161.62

116.07

113.99

173.36

126.38

119.57

91.25

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

0.41

0.63

0.46

0.72

0.68

0.63

0.64

Selling and Distribution Expenses

167.23

167.45

179.10

159.15

174.27

159.66

125.45

Other Expenses

-0.04

-0.06

-0.05

-0.07

-0.06

4.45

Total Expenditure (Excl Depreciation)

328.86

283.52

293.09

332.51

300.65

279.23

261.89

Operating Profit (PBDIT) excl Other Income

138

-91.1

-104.5

249.4

109.7

-5.1

-31.8

Other Income

0.04

1.25

3.45

-0.91

0.48

-9.04

21.94

Operating Profit (PBDIT)

166.59

-62.55

-72.36

276.07

136.90

6.69

12.84

Interest

0.41

0.63

0.46

0.72

0.68

0.63

0.64

Exceptional Items

0.00

17.99

3.67

0.00

20.85

4.23

0.00

Gross Profit (PBDT)

305.22

76.31

74.64

408.54

283.94

154.60

138.86

Depreciation

28.56

27.34

28.65

27.60

26.76

20.80

22.67

Profit Before Tax

137.62

-72.53

-97.80

247.75

130.31

-10.51

-10.47

Tax

-3.42

24.65

-49.85

36.60

1.67

24.92

-25.16

Provisions and contingencies

0.00

Profit After Tax

141.03

-97.18

-47.95

211.15

128.64

-35.42

14.69

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

141.03

-97.18

-47.95

211.15

128.64

-35.42

14.69

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

141.03

-97.18

-47.95

211.15

128.64

-35.42

14.69

Equity Capital

0.00

Face Value

0.0

Reserves

1,807.87

1,686.33

1,908.60

2,074.17

1,926.40

1,812.70

1,946.71

Earnings per share (EPS)

25.06

-17.11

-8.31

36.22

21.74

-5.99

2.48

Diluted Earnings per share

25.06

-17.11

-8.31

36.22

21.74

-5.99

2.48

Operating Profit Margin (Excl OI)

29.56%

-47.38%

-55.38%

42.86%

26.73%

-1.85%

-13.81%

Gross Profit Margin

35.6%

-23.49%

-36.66%

47.32%

38.28%

3.75%

5.3%

PAT Margin

30.21%

-50.51%

-25.42%

36.29%

31.35%

-12.92%

6.38%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Dec 2025 is 13.77% vs 3.17% in Dec 2024

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 9.64% vs 17.77% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 22.07% vs 9.03% in Dec 2024

Interest

YoY Growth in quarter ended Dec 2025 is -42.86% vs 40.00% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of Human Metabolome Technologies, Inc. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(JPY)

Change(%)

Net Sales

466.84

0.00

466.84

Other Operating Income

0.00

Total Operating income

466.84

0.00

466.84

Raw Material Cost

161.62

0.00

161.62

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

0.41

0.62

-0.21

-33.87%

Selling and Distribution Expenses

167.23

49.37

117.86

238.73%

Other Expenses

-0.04

34.68

-34.72

-100.12%

Total Expenditure (Excl Depreciation)

328.86

396.77

-67.91

-17.12%

Operating Profit (PBDIT) excl Other Income

137.98

-396.77

534.75

134.78%

Other Income

0.04

47.02

-46.98

-99.91%

Operating Profit (PBDIT)

166.59

-349.75

516.34

147.63%

Interest

0.41

0.62

-0.21

-33.87%

Exceptional Items

0.00

-0.33

0.33

100.00%

Gross Profit (PBDT)

305.22

0.00

305.22

Depreciation

28.56

0.00

28.56

Profit Before Tax

137.62

-350.70

488.32

139.24%

Tax

-3.42

0.24

-3.66

-1,525.00%

Provisions and contingencies

0.00

Profit After Tax

141.03

-350.94

491.97

140.19%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

141.03

-350.94

491.97

140.19%

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

141.03

-350.94

491.97

140.19%

Equity Capital

0.00

Face Value

0.00

Reserves

1,807.87

2,793.30

-985.43

-35.28%

Earnings per share (EPS)

25.06

-3.94

29.00

736.04%

Diluted Earnings per share

25.06

-3.94

29.00

736.04%

Operating Profit Margin (Excl OI)

29.56%

0.00%

0.00

29.56%

Gross Profit Margin

35.60%

0.00%

0.00

35.60%

PAT Margin

30.21%

0.00%

0.00

30.21%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 46.68 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 142.62% vs 2.01% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 13.77% vs 3.17% in Dec 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 14.10 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 245.06% vs -102.50% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 9.64% vs 17.77% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 16.65 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 360.97% vs 15.83% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 22.07% vs 9.03% in Dec 2024

Quarterly - Interest

Interest 0.04 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is -33.33% vs 20.00% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -42.86% vs 40.00% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 29.56%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024